Robot-assisted radical hysterectomy reduced mostly low-grade intraoperative complications vs open surgery in early-stage cervical cancer.
|Articles|December 1, 2008
- ONCOLOGY Vol 22 No 14
- Volume 22
- Issue 14
FDA Approves New Imaging System to Enhance Cervical Cancer Detection
BD Diagnostics recently announced that it received US Food and Drug Administration (FDA) Premarket Approval for the BD FocalPoint GS Imaging System.
Advertisement
BD Diagnostics recently announced that it received US Food and Drug Administration (FDA) Premarket Approval for the BD FocalPoint GS Imaging System. This innovative new system is designed to enhance cervical cancer screening for cytology laboratories using the BD SurePath Pap test slides to detect evidence of squamous carcinoma, adenocarcinoma and their usual precursor conditions.
Articles in this issue
almost 18 years ago
The Absent-Minded Professor: An Unusual Complication of Melanomaalmost 18 years ago
Inflammatory Breast Cancer: A Complex Diseasealmost 18 years ago
Defining the IBC Phenotypealmost 18 years ago
Acupuncturealmost 18 years ago
Two Orphan Drug Designations Granted for Reviroc in NHLalmost 18 years ago
NDA Submitted for Trabectedin to Treat Relapsed Ovarian Canceralmost 18 years ago
FDA Considers Update for Tanning Bed LabelsAdvertisement
Related to this article
Advertisement
Advertisement
Trending on CancerNetwork
1
Larger Prostates Showed Post-Radiotherapy Urinary Symptom Normalization
2
Sequencing Bispecifics and CAR T-Cell Therapy in Myeloma and AL Amyloidosis
3
Weighing the Promise and Trade-offs of CAR NK Cell Therapy for Cancer
4
Building a Low-Dose Radiation Therapy Program for Benign Disease
5